Seizert Capital Partners’s Utah Medical Products UTMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$309K Sell
5,436
-133
-2% -$7.57K 0.01% 147
2025
Q1
$312K Hold
5,569
0.01% 137
2024
Q4
$342K Sell
5,569
-167
-3% -$10.3K 0.02% 139
2024
Q3
$384K Buy
5,736
+2,112
+58% +$141K 0.02% 136
2024
Q2
$242K Sell
3,624
-495
-12% -$33.1K 0.01% 154
2024
Q1
$293K Hold
4,119
0.01% 150
2023
Q4
$347K Sell
4,119
-1,141
-22% -$96.1K 0.02% 140
2023
Q3
$452K Sell
5,260
-652
-11% -$56.1K 0.02% 132
2023
Q2
$551K Sell
5,912
-357
-6% -$33.3K 0.03% 128
2023
Q1
$594K Sell
6,269
-1,478
-19% -$140K 0.03% 131
2022
Q4
$779K Hold
7,747
0.04% 134
2022
Q3
$661K Sell
7,747
-2,683
-26% -$229K 0.04% 132
2022
Q2
$896K Hold
10,430
0.05% 139
2022
Q1
$937K Hold
10,430
0.04% 143
2021
Q4
$1.04M Hold
10,430
0.05% 135
2021
Q3
$968K Sell
10,430
-509
-5% -$47.2K 0.04% 129
2021
Q2
$930K Buy
10,939
+6,943
+174% +$590K 0.04% 132
2021
Q1
$346K Hold
3,996
0.02% 163
2020
Q4
$337K Buy
3,996
+585
+17% +$49.3K 0.02% 145
2020
Q3
$272K Buy
3,411
+177
+5% +$14.1K 0.02% 153
2020
Q2
$287K Sell
3,234
-470
-13% -$41.7K 0.02% 161
2020
Q1
$348K Buy
+3,704
New +$348K 0.03% 140
2019
Q4
Sell
-3,572
Closed -$342K 222
2019
Q3
$342K Hold
3,572
0.02% 171
2019
Q2
$342K Sell
3,572
-291
-8% -$27.9K 0.02% 174
2019
Q1
$341K Buy
+3,863
New +$341K 0.02% 186
2018
Q4
Sell
-2,387
Closed -$225K 221
2018
Q3
$225K Sell
2,387
-3,317
-58% -$313K 0.01% 213
2018
Q2
$564K Hold
5,704
0.02% 148
2018
Q1
$564K Hold
5,704
0.02% 148
2017
Q4
$464K Sell
5,704
-808
-12% -$65.7K 0.02% 150
2017
Q3
$479K Hold
6,512
0.02% 154
2017
Q2
$471K Buy
6,512
+320
+5% +$23.1K 0.02% 162
2017
Q1
$386K Hold
6,192
0.01% 178
2016
Q4
$450K Hold
6,192
0.02% 178
2016
Q3
$370K Buy
6,192
+1,782
+40% +$106K 0.01% 182
2016
Q2
$278K Sell
4,410
-690
-14% -$43.5K 0.01% 201
2016
Q1
$319K Buy
+5,100
New +$319K 0.01% 197